Press Releases from DelveInsight Business Research (5939 total)
Duchenne Muscular Dystrophy Pipeline Insights 2024: Therapies, Clinical Trials, …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Duchenne Muscular Dystrophy pipeline constitutes 75+ key companies continuously working towards developing 75+ Duchenne…
Dyslipidemia Pipeline 2024: Clinical Trials Assessment, FDA Approvals, Therapies …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Dyslipidemia pipeline constitutes key companies continuously working towards developing Dyslipidemia treatment therapies, analysis of…
Alcohol Use Disorder Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, …
(Albany, USA) DelveInsight's, "Alcohol Use Disorder Pipeline Insight, 2024" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Alcohol Use Disorder pipeline…
Adeno-Associated Virus (AAV) Vectors in Gene Therapy Clinical Trials 2024: EMA, …
(Albany, USA) DelveInsight's, "AAV Vectors in Gene Therapy Pipeline Insight 2024" report provides comprehensive insights about 180+ companies and 235+ pipeline drugs in AAV vectors…
Adrenocortical Carcinoma Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medicat …
(Albany, United States) As per DelveInsight's assessment, globally, Adrenocortical Carcinoma pipeline constitutes 5+ key companies continuously working towards developing 5+ Adrenocortical Carcinoma treatment therapies, analysis…
Acute Lymphocytic Leukemia Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medic …
(Albany, USA) DelveInsight's, "Acute Lymphocytic Leukemia Pipeline Insight 2024" report provides comprehensive insights about 150+ companies and 160+ pipeline drugs in the Acute Lymphocytic Leukemia…
Age-related Vision Dysfunction Clinical Trials 2024: EMA, PDMA, FDA Approvals, M …
(Albany, United States) As per DelveInsight's assessment, globally, Age-related Vision Dysfunction pipeline constitutes 8+ key companies continuously working towards developing 8+ Age-related Vision Dysfunction treatment…
Chlamydia Infections Clinical Trials 2024: FDA Approvals, Clinical Trials, Thera …
(Albany, USA) DelveInsight's, "Chlamydia Infections Pipeline Insight, 2024," report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Chlamydia Infections pipeline landscape. It…
Treatment Resistant Depression Pipeline Analysis 2024: FDA Approvals, Clinical T …
(Albany, United States) As per DelveInsight's assessment, globally, Treatment Resistant Depression pipeline constitutes 25+ key companies continuously working towards developing 25+ Treatment Resistant Depression treatment…
Usher Syndrome Pipeline Analysis 2024: EMA, PDMA, FDA Approvals, Clinical Trials …
(Albany, United States) As per DelveInsight's assessment, globally, Usher Syndrome pipeline constitutes 5+ key companies continuously working towards developing 7+ Usher Syndrome treatment therapies, analysis…
Renal Tubular Acidosis Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medicatio …
(Albany, United States) As per DelveInsight's assessment, globally, Renal Tubular Acidosis pipeline constitutes 5+ key companies continuously working towards developing 5+ Renal Tubular Acidosis treatment…
Venous Thromboembolism Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medicatio …
(Albany, United States) As per DelveInsight's assessment, globally, Venous Thromboembolism pipeline constitutes 10+ key companies continuously working towards developing 10+ Venous Thromboembolism treatment therapies, analysis…
Exocrine Pancreatic Insufficiency Clinical Trials 2024: EMA, PDMA, FDA Approvals …
(Albany, United States) As per DelveInsight's assessment, globally, Exocrine Pancreatic Insufficiency pipeline constitutes 5+ key companies continuously working towards developing 5+ Exocrine Pancreatic Insufficiency treatment…
Bullous Pemphigoid Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, T …
(Albany, United States) As per DelveInsight's assessment, globally, Bullous pemphigoid pipeline constitutes 4+ key companies continuously working towards developing 4+ Bullous pemphigoid treatment therapies, analysis…
Post Bariatric Hypoglycemia Market Forecasted to Surge in Coming Years, 2024-203 …
DelveInsight's "Post Bariatric Hypoglycemia Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Post Bariatric Hypoglycemia, historical and forecasted epidemiology as…
Oligometastatic Disease Market Report 2034: Epidemiology Data, Pipeline Therapie …
DelveInsight's "Oligometastatic Disease Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Oligometastatic Disease, historical and forecasted epidemiology as well as…
Parkinson's Disease Psychosis Pipeline Update 2024: FDA Approvals, Therapeutic A …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Parkinson's Disease Psychosis pipeline constitutes 5+ key companies continuously working towards developing 5+ Parkinson's…
Ovarian Cancer Pipeline Assessment 2024: Therapies, Clinical Trials, Latest FDA, …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Ovarian Cancer pipeline constitutes 180+ key companies continuously working towards developing 200+ Ovarian Cancer…
PH-ILD Pipeline 2024: Clinical Trials Assessment, FDA Approvals, Therapies, and …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, PH-ILD pipeline constitutes key companies continuously working towards developing PH-ILD treatment therapies, analysis of…
Hepatitis C Virus Infection Pipeline Forecast 2024: FDA Approvals: Analysis of C …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Hepatitis C Virus Infection pipeline constitutes 20+ key companies continuously working towards developing 20+…
Herpes Simplex Pipeline Trends 2024: Clinical Trials, Therapeutic Innovations, T …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Herpes Simplex pipeline constitutes 15+ key companies continuously working towards developing 20+ Herpes Simplex…
High-Grade Glioma Pipeline Update 2024: FDA Approvals, Therapeutic Advancements, …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, High-Grade Glioma pipeline constitutes 150+ key companies continuously working towards developing 150+ High-Grade Glioma…
Prurigo Nodularis Pipeline Insights 2024: Therapies, Clinical Trials, and Therap …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Prurigo Nodularis pipeline constitutes 5+ key companies continuously working towards developing 5+ Prurigo Nodularis…
Sarcopenia Pipeline Analysis 2024: FDA Approvals, Medication, Clinical Trials, T …
(Albany, United States) As per DelveInsight's assessment, globally, Sarcopenia pipeline constitutes 10+ key companies continuously working towards developing 10+ Sarcopenia treatment therapies, analysis of Clinical…
Thrombocytopenia Pipeline Analysis 2024: EMA, PDMA, FDA Approvals, Clinical Tria …
(Albany, United States) As per DelveInsight's assessment, globally, Thrombocytopenia pipeline constitutes 25+ key companies continuously working towards developing 25+ Thrombocytopenia treatment therapies, analysis of Clinical…
Hepatic Encephalopathy Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medicatio …
(Albany, United States) As per DelveInsight's assessment, globally, Hepatic Encephalopathy pipeline constitutes 3+ key companies continuously working towards developing 3+ Hepatic Encephalopathy treatment therapies, analysis…
Hemophilia B Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Therapi …
(Albany, USA) As per DelveInsight's assessment, globally, about 15+ key pharma and biotech companies are working on 20+ pipeline drugs in the Hemophilia B therapeutics…
Homocystinuria Pipeline Analysis 2024: FDA Approvals, Clinical Trials, Therapies …
(Albany, United States) As per DelveInsight's assessment, globally, Homocystinuria pipeline constitutes 3+ key companies continuously working towards developing 3+ Homocystinuria treatment therapies, analysis of Clinical…
Clostridium Difficile Infections Clinical Trials 2024: EMA, PDMA, FDA Approvals, …
(Albany, United States) As per DelveInsight's assessment, globally, Clostridium Difficile Infections pipeline constitutes 20+ key companies continuously working towards developing 22+ Clostridium Difficile Infections treatment…
Complicated Urinary Tract Infection (UTI) Clinical Trials 2024: EMA, PDMA, FDA A …
(Albany, United States) As per DelveInsight's assessment, globally, about 12+ key pharma and biotech companies are working on 12+ pipeline drugs in the Complicated Urinary…
IgG4-Related Disease Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, …
(Albany, United States) As per DelveInsight's assessment, globally, IgG4-Related Disease pipeline constitutes 10+ key companies continuously working towards developing 10+ IgG4-Related Disease treatment therapies, analysis…
Acute Pain Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Treatment …
(Albany, United States) As per DelveInsight's assessment, globally, Acute Pain pipeline constitutes 25+ key companies continuously working towards developing 25+ Acute Pain treatment therapies, analysis…
Acute On Chronic Liver Failure Clinical Trials 2024: EMA, PDMA, FDA Approvals, M …
(Albany, United States) As per DelveInsight's assessment, globally, Acute On Chronic Liver Failure pipeline constitutes 4+ key companies continuously working towards developing 6+ Acute On…
PD-1 Non-Small Cell Lung Cancer Clinical Trials 2024: EMA, PDMA, FDA Approvals, …
The prevalence of non-small cell lung cancer has been rising over the past few years, which prompts a growing demand for treatment options. The introduction…
Fabry Disease Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Treatm …
(Albany, United States) As per DelveInsight's assessment, globally, Fabry Disease pipeline constitutes 18+ key companies continuously working towards developing 18+ Fabry Disease treatment therapies, analysis…
Systemic Sclerosis Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, T …
(Albany, USA) DelveInsight's, "Systemic Sclerosis Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in the Systemic Sclerosis pipeline landscape.…
Ankylosing Spondylitis Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medicatio …
(Albany, United States) As per DelveInsight's assessment, globally, Ankylosing Spondylitis pipeline constitutes 20+ key companies continuously working towards developing 20+ Ankylosing Spondylitis treatment therapies, analysis…
NSCLC Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Pipeline, Drug …
(Albany, USA) DelveInsight's, "Non-Small-Cell Lung Cancer Pipeline Insight 2024" report provides comprehensive insights about 135+ NSCLC Companies and 150+ pipeline drugs in the Non-Small-Cell Lung…
Non-muscle Invasive Bladder Cancer (NMIBC) Clinical Trials 2024: EMA, PDMA, FDA …
(Albany, USA) DelveInsight's, "Non Muscle Invasive Bladder Cancer Pipeline Insight 2024" report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Non Muscle…
Crohn's Disease Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Ther …
(Albany, United States) As per DelveInsight's assessment, globally, Crohn's Disease pipeline constitutes 70+ key companies continuously working towards developing 80+ Crohn's Disease treatment therapies, analysis…
Hemophilia A Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Therapi …
Hemophilia A companies are Spark Therapeutics, Sigilon Therapeutics, ASC Therapeutics, Pfizer, Sanofi Genzyme, Novo Nordisk, Hoffmann-La Roche, Chugai Pharmaceutical, Shire, Pfizer, BioMarin Pharmaceutical, Sinocelltech Ltd,…
Ascites Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Therapies, M …
(Albany, United States) As per DelveInsight's assessment, globally, Ascites pipeline constitutes 10+ key companies continuously working towards developing 10+ Ascites treatment therapies, analysis of Clinical…
Genital Warts Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Therap …
(Albany, United States) As per DelveInsight's assessment, globally, Genital Warts pipeline constitutes 30+ key companies continuously working towards developing 30+ Genital Warts treatment therapies, analysis…
Giant-Cell Arteritis Clinical Trials 2024: FDA Approvals, Medication, Therapies, …
(Albany, United States) As per DelveInsight's assessment, globally, Giant-Cell Arteritis pipeline constitutes 6+ key companies continuously working towards developing 6+ Giant-Cell Arteritis treatment therapies, analysis…
Mydriasis Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Therapies, …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Mydriasis pipeline constitutes 3+ key companies continuously working towards developing 3+ Mydriasis treatment therapies, analysis…
Nasal Polyposis Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Ther …
(Albany, United States) As per DelveInsight's assessment, globally, Nasal Polyposis pipeline constitutes 4+ key companies continuously working towards developing 4+ Nasal Polyposis treatment therapies, analysis…
Aplastic Anemia Clinical Trials 2024: EMA, PDMA, FDA Approvals, Pipeline, Medica …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Aplastic Anemia pipeline constitutes 5+ key companies continuously working towards developing 8+ Aplastic Anemia treatment…
Eosinophilic Esophagitis Clinical Trials 2024: FDA Approvals, Medication, Therap …
(Albany, USA) DelveInsight's, "Eosinophilic Esophagitis Pipeline Insight 2024" report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in the Eosinophilic Esophagitis pipeline landscape.…
Essential Thrombocythemia Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medica …
(Albany, United States) As per DelveInsight's assessment, globally, Essential Thrombocythemia pipeline constitutes 6+ key companies continuously working towards developing 6+ Essential Thrombocythemia treatment therapies, analysis…
IgA nephropathy Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Ther …
IgA nephropathy companies are Chinook Therapeutics, Inc., RemeGen Co., Ltd., Novartis, Jiangsu HengRui Medicine Co., Ltd., Ionis Pharmaceuticals, Inc., Vera Therapeutics, Inc., Eledon Pharmaceuticals, Guangdong…
